189 related articles for article (PubMed ID: 14520710)
41. Expression patterns of potential therapeutic targets in prostate cancer.
Zellweger T; Ninck C; Bloch M; Mirlacher M; Koivisto PA; Helin HJ; Mihatsch MJ; Gasser TC; Bubendorf L
Int J Cancer; 2005 Feb; 113(4):619-28. PubMed ID: 15472903
[TBL] [Abstract][Full Text] [Related]
42. Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients.
Le Page C; Koumakpayi IH; Alam-Fahmy M; Mes-Masson AM; Saad F
Br J Cancer; 2006 Jun; 94(12):1906-12. PubMed ID: 16721361
[TBL] [Abstract][Full Text] [Related]
43. Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men.
Shimizu Y; Segawa T; Inoue T; Shiraishi T; Yoshida T; Toda Y; Yamada T; Kinukawa N; Terada N; Kobayashi T; Kinoshita H; Kamoto T; Nakamura E; Ogawa O
BJU Int; 2007 Sep; 100(3):685-90. PubMed ID: 17542985
[TBL] [Abstract][Full Text] [Related]
44. Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions.
Merseburger AS; Hennenlotter J; Simon P; Müller CC; Kühs U; Knüchel-Clarke R; Moul JW; Stenzl A; Kuczyk MA
Oncol Rep; 2006 Jul; 16(1):79-83. PubMed ID: 16786126
[TBL] [Abstract][Full Text] [Related]
45. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J
Cancer Res; 2005 Jul; 65(13):5730-9. PubMed ID: 15994948
[TBL] [Abstract][Full Text] [Related]
46. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
47. BP1, a homeoprotein, is significantly expressed in prostate adenocarcinoma and is concordant with prostatic intraepithelial neoplasia.
Schwartz AM; Man YG; Rezaei MK; Simmens SJ; Berg PE
Mod Pathol; 2009 Jan; 22(1):1-6. PubMed ID: 18931648
[TBL] [Abstract][Full Text] [Related]
48. Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers.
Weng J; Wang J; Cai Y; Stafford LJ; Mitchell D; Ittmann M; Liu M
Int J Cancer; 2005 Feb; 113(5):811-8. PubMed ID: 15499628
[TBL] [Abstract][Full Text] [Related]
49. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
50. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
51. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
52. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.
Paweletz CP; Charboneau L; Bichsel VE; Simone NL; Chen T; Gillespie JW; Emmert-Buck MR; Roth MJ; Petricoin III EF; Liotta LA
Oncogene; 2001 Apr; 20(16):1981-9. PubMed ID: 11360182
[TBL] [Abstract][Full Text] [Related]
53. c-met proto-oncogene expression in benign and malignant human prostate tissues.
Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of cyclooxygenase-2 in human prostate carcinoma and prostatic intraepithelial neoplasia-association with increased expression of Polo-like kinase-1.
Denkert C; Thoma A; Niesporek S; Weichert W; Koch I; Noske A; Schicktanz H; Burkhardt M; Jung K; Dietel M; Kristiansen G
Prostate; 2007 Mar; 67(4):361-9. PubMed ID: 17265445
[TBL] [Abstract][Full Text] [Related]
55. Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue.
Jonmarker S; Glaessgen A; Culp WD; Pisa P; Lewensohn R; Ekman P; Valdman A; Egevad L
APMIS; 2008 Jun; 116(6):491-8. PubMed ID: 18754323
[TBL] [Abstract][Full Text] [Related]
56. Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients.
Lehnigk U; Zimmermann U; Woenckhaus C; Giebel J
Histol Histopathol; 2005 Jul; 20(3):673-80. PubMed ID: 15944914
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis.
Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
Hum Pathol; 2011 Dec; 42(12):1931-6. PubMed ID: 21676431
[TBL] [Abstract][Full Text] [Related]
58. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
59. Limited significance of activated Akt-mammalian target of rapamycin signaling pathway in prostate cancer progression.
Ko YH; Miyake H; Behnsawy HM; Cheon J; Fujisawa M
Urol Int; 2014; 93(2):146-51. PubMed ID: 24556942
[TBL] [Abstract][Full Text] [Related]
60. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]